B

Biohaven Ltd
D

BHVN

11.020
USD
0.04
(0.32%)
Post Trading
حجم التداول
79,108
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
1,458,909,937
أصول ذات صلة الأخبار المقالات

العنوان: Biohaven Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.